Cyberonics Receives FDA Approval to Combine VNS Device Manuals for Epilepsy & Depression

July 24, 2006 Cyberonics Receives FDA Approval to Combine VNS Device Manuals for Epilepsy & Depression Cyberonics Inc., announced on July 12, 2006, that the U.S. Food and Drug Administration (FDA) has decided to allow the company to create a new comprehensive treatment manual for its Vagus Nerve Stimulation (VNS) Device by combining the manual for refractory epilepsy with the one for treatment-resistant depression. VNS Therapy has been approved for treating both disorders, and until receiving FDA approval, was required to maintain two individual treatment manuals and labeling formats. The combined manual, the Pulse Generator Physician's Manual . . .